Strata Critical CEO receives performance share award
Strata Critical Medical, Inc. CEO, Logistics Scott M. Wunsch reported equity compensation activity involving Class A common stock.
Rhea-AI Filing Summary
Strata Critical Medical, Inc. CEO, Logistics Scott M. Wunsch reported equity compensation activity involving Class A common stock. On April 23, 2026, he acquired 57,172 shares at $0.0000 per share as a grant tied to performance-based restricted stock units that vested after meeting certified performance criteria.
On April 24, 2026, the company withheld 13,922 shares at $4.92 per share to cover tax obligations related to the PSU vesting, a non-market disposition. Following these transactions, he held 631,124 shares directly and 382,987 shares indirectly through a limited liability company he solely owns.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Class A common stock, $0.0001 par value per share | 13,922 | $4.92 | $68K |
| Grant/Award | Class A common stock, $0.0001 par value per share | 57,172 | $0.00 | $0.00 |
| holding | Class A common stock, $0.0001 par value per share | -- | -- | -- |
Footnotes (3)
- F1. Represents shares that were acquired upon the certification of the Compensation Committee of the Issuer's Board of Directors of the satisfaction of performance criteria underlying an award of performance-based restricted stock units ("PSUs") granted to the Reporting Person on March 20, 2025.
- F2. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of PSUs.
- F3. Held directly by a limited liability company of which the Reporting Person is the sole member.
Key Figures
Key Terms
performance-based restricted stock units financial
PSUs financial
tax withholding obligations financial
Compensation Committee financial
limited liability company financial
FAQ
What insider transactions did SRTA CEO Scott Wunsch report on this Form 4?
Was the SRTA CEO’s Form 4 transaction an open-market stock sale?
Does the SRTA Form 4 show any remaining derivative or option positions for the CEO?
AI-generated analysis. How Rhea-AI works. Not financial advice.